Emeritus Faculty, Academic Council, Psychiatry and Behavioral Science, Stanford University Medical Center
Psychiatry
Dr. Lorrin M. Koran, MD
|
|
Give Review
Doctor Lorrin M. Koran, MD practices Psychiatry. He went to medical school at Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1 in research and 12 in primary care medicine Lorrin M. Koran is also published. He has 101 publications published. The lastest publication: "Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.'
Publications
- Excoriation (skin-picking) disorder in adults: a cross-cultural survey of Israeli Jewish and Arab samples.
- Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications.
- Open-label trial of aripiprazole in the treatment of trichotillomania.
- Agitation in the inpatient psychiatric setting: a review of clinical presentation, burden, and treatment.
- A double-blind, placebo-controlled trial of topiramate for pathological gambling.
- Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.
- Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.
- Body dysmorphic disorder: some key issues for DSM-V.
- The prevalence of pathologic skin picking in US adults.
- Adequacy of pharmacotherapy among medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder.
- Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder.
- Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients.
- The prevalence of body dysmorphic disorder in the United States adult population.
- Duloxetine treatment of dysthymia and double depression: an open-label trial.
- Escitalopram for compulsive buying disorder: a double-blind discontinuation study.
- Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation.
- Potential markers for problematic internet use: a telephone survey of 2,513 adults.
- Estimated prevalence of compulsive buying behavior in the United States.
- Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder.
- High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
- Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
- Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder.
- Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study.
- Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
- A case of kleptomania correlating with premenstrual dysphoria.
- Serotonin-1D hypothesis of obsessive-compulsive disorder: an update.
- Overview of Kleptomania and Phenomenological Description of 40 Patients.
- A 1-year naturalistic follow-up of patients with compulsive shopping disorder.
- Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation.
- A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
- Venlafaxine in treatment-resistant obsessive-compulsive disorder.
- Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
- Medical disorders among patients admitted to a public-sector psychiatric inpatient unit.
- Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
- Citalopram treatment of compulsive shopping: an open-label study.
- Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
- Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
- Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder.
- Refractory obsessive-compulsive disorder: state-of-the-art treatment.
- Clinical skills. Quantitative measurement.
- Letter: Public hysteria and medical practice.
- Time course of salamander spinal cord regeneration and recovery of swimming: HRP retrograde pathway tracing and kinematic analysis.
- Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
- Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
- A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
- A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
- The undertreatment of dysthymia.
- Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.
- Memantine for treatment-resistant OCD.
- Clinical characteristics of schizotypal-related obsessive-compulsive disorder.
- Psychopharmacology of compulsive buying.
- Treatment non-response in OCD: methodological issues and operational definitions.
- Patients with obsessive-compulsive disorder vs depression have comparable health care costs: A retrospective claims analysis of Florida Medicaid enrollees.
- A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
- The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization.
- Mirtazapine treatment of obsessive-compulsive disorder.
- Fluoxetine in pathologic skin-picking: open-label and double-blind results.
- Sertraline versus imipramine to prevent relapse in chronic depression.
- Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.
- Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
- Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization.
- Quality of life in obsessive-compulsive disorder.
- Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.
- Lost human capital from early-onset chronic depression.
- Citalopram for treatment-resistant obsessive-compulsive disorder.
- Hoarding in obsessive-compulsive disorder: a report of 20 cases.
- Citalopram and sexual side effects of selective serotonin reuptake inhibitors.
- Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
- The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
- The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, conti...
- Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks.
- Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder.
- A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
- Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum.
- Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder.
- Electroconvulsive therapy.
- Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
- Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study Group.
- Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
- Predicting response to fluoxetine in geriatric patients with major depression.
- Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.
- Quality of life for patients with obsessive-compulsive disorder.
- Comparing the cost effectiveness of psychiatric treatments: bulimia nervosa.
- Fluoxetine for isolated sleep paralysis.
- Maximizing clinical revenues of psychiatric consultation-liaison services. An economic commentary.
- One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa.
- A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder.
- Intravenous clomipramine for obsessive-compulsive disorder.
- Do soft signs predict treatment outcome in obsessive-compulsive disorder?
- Psychiatrists' patients.
- Mental health expenditures in California counties.
- Psychiatrists' distribution across the 50 states, 1978.
- Changing hospital work environments: an example of a burn unit.
- Recruitment of institutional psychiatrists for the 50 states.
- Mobile medical screening teams for public programs.
- Detecting physical illness in patients with mental disorders.
- Lithium prophylaxis of prednisone psychosis: a case report.
- [Treatment of drug addicts with narcotic and non-narcotic drugs].
- Compatibility and cohesiveness in group psychotherapy.
- Early termination from group psychotherapy.
Schools
Harvard Medical School
UCLA Med Center
Stanford Med Center
Maudsley Hospital Institute Psychology
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Stanford University -
UCLA Medical Center -
Harvard Medical School
Hospital
-
Stanford Health Care
Helpful Reviews
Similar Doctors
|
|
Dr. Po W. Wang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard Fisch, MD |
|
|
Dr. Tina T. Lee, MD |